BMW's Double Squeeze: Recall Fatigue Meets a Sharper-Than-Expected Profit Wound
Published on 08/20/2026 at 12:34 | Redaktion boerse-global.de
The 58-euro price tag on BMW's common shares is starting to look less like a valuation and more like a dare. With the stock hovering barely 3 percent above its 52-week floor of 56.40 euros, the Munich automaker is fielding two distinct but compounding pressures: a profit slide that has accelerated far beyond management's own forecasts, and a burst of technical recalls that has arrived at precisely the wrong moment for investor sentiment.
The second-quarter numbers, delivered on August 14, laid the damage bare. Net profit fell roughly 35 percent year-on-year to 1.2 billion euros, while earnings per share dropped to 2.05 euros from 2.85 euros in the same period of 2025. Group revenue contracted 7.86 percent to 31.26 billion euros, and the operating result in the automotive division took the hardest hit, collapsing more than 60 percent to just 629 million euros. The first quarter had already shown a 23 percent decline in earnings to roughly 1.67 billion euros, confirming a two-quarter trend that has left little room for optimism.
The most acute pressure point remains China. BMW delivered just 117,815 vehicles there in the second quarter, a 30.2 percent plunge, bringing the first-half decline in its largest single market to 20.4 percent. That weakness, combined with intensifying competition in Europe, prompted RBC Capital Markets to trim its price target on the common shares from 62.00 to 60.00 euros on August 14. HSBC had earlier moved the other way, upgrading from Hold to Buy in mid-July while simultaneously cutting its target from 79 to 71 euros — a gesture that acknowledged the fundamental deterioration even as it signaled relative optimism.
Management has responded with a blunt cost-cutting program. The company announced it will eliminate roughly 8,000 positions by the end of 2027, more than half of them in Germany, where about 85,000 of the group's 154,000 employees are based. A voluntary severance scheme is slated to begin in October. The personnel reduction follows a June decision to scrap the full-year outlook: BMW now expects a slight decline in automotive deliveries for 2026, with the EBIT margin forecast slashed from 4-6 percent to 1-3 percent and return on capital cut from 6-10 percent to 1-5 percent. Additional one-off charges in the second half will weigh on results before the efficiency measures begin to pay off in subsequent years.
Should investors sell immediately? Or is it worth buying BMW?
The recall situation adds an unwelcome layer of complexity. BMW has announced a recall for 5 Series, 7 Series, and 8 Series sedans over a parking brake defect that could allow vehicles to roll away unintentionally. The news follows a series of technical recalls in recent weeks, including a global recall of the S 1000 RR motorcycle over issues affecting the engine, ABS, and lighting. Individually, such actions are routine in the auto industry. Collectively, they land at a delicate moment when investors are scrutinizing every signal for signs of deeper quality problems — particularly as BMW pushes forward with the "Neue Klasse" strategy and the start of series production for the all-electric i3 sedan in Munich.
For shareholders, the question is whether these recalls remain isolated technical events with manageable costs or whether they signal a broader quality issue that could compound the margin pressure. The recalls have not triggered sales or registration bans, which supports the more benign interpretation. The repositioning of the ALPINA brand as an exclusive luxury segment could also open new revenue streams. On the bearish side, the stock trades roughly 2 percent below its 50-day moving average, suggesting the short-term momentum remains negative, and the proximity to the 52-week low leaves little cushion if further quality problems emerge.
One counterweight to the gloom: BMW has kept its share buyback program running despite the operational strain. The third tranche, launched in early July, allows for purchases of up to 625 million euros, or a maximum of 44 million common shares. In August, the company acquired approximately 1.12 million of its own shares across two weekly periods — a signal that management sees value in the equity even as critics note the capital could be deployed elsewhere during a restructuring.
There is also a leadership transition in motion. Dorothea von Boxberg will take over the human resources portfolio from Ilka Horstmeier in September, stepping into the role just as the job cuts begin to unfold.
The stock closed recently at 58.64 euros, down 37 percent since the start of the year and roughly 41 percent below its early December high of 97.90 euros. The 52-week low of 56.40 euros was marked only a few weeks ago, and the recent 1.7 percent decline over seven trading sessions suggests selling pressure has yet to abate. The next meaningful test will come with further operational data following the weak second quarter, and whether the Neue Klasse push and i3 production can generate visible momentum in sales and margins. Until then, the shares remain a bet on whether the cost cuts and strategic repositioning can outrun the structural drag from China and Europe — with recalls adding an unwelcome variable to the equation.
Ad
BMW Stock: New Analysis - 20 August
Fresh BMW information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
